Exchange Traded Concepts, LLC Supernus Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $10.4 Billion
  • Q3 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 17,550 shares of SUPN stock, worth $779,922. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,550
Previous 25,365 30.81%
Holding current value
$779,922
Previous $799,000 4.88%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025
SELL
$31.45 - $47.79 $245,781 - $373,478
-7,815 Reduced 30.81%
17,550 $838,000
Q2 2025

Jul 10, 2025
BUY
$30.29 - $33.43 $14,660 - $16,180
484 Added 1.95%
25,365 $799,000
Q1 2025

Apr 17, 2025
BUY
$31.17 - $40.0 $86,091 - $110,480
2,762 Added 12.49%
24,881 $814,000
Q4 2024

Jan 21, 2025
BUY
$31.89 - $37.83 $17,858 - $21,184
560 Added 2.6%
22,119 $799,000
Q3 2024

Oct 10, 2024
BUY
$25.77 - $35.16 $555,575 - $758,014
21,559 New
21,559 $672,000
Q4 2023

Jan 05, 2024
BUY
$22.72 - $29.68 $7,611 - $9,942
335 Added 0.8%
42,189 $1.22 Million
Q3 2023

Oct 18, 2023
BUY
$27.57 - $32.91 $727,572 - $868,494
26,390 Added 170.65%
41,854 $1.15 Million
Q2 2023

Jul 20, 2023
SELL
$29.91 - $38.73 $15,254 - $19,752
-510 Reduced 3.19%
15,464 $464,000
Q1 2023

Apr 12, 2023
SELL
$34.93 - $42.03 $138,462 - $166,606
-3,964 Reduced 19.88%
15,974 $578,000
Q4 2022

Jan 17, 2023
BUY
$31.09 - $37.88 $16,788 - $20,455
540 Added 2.78%
19,938 $711,000
Q3 2022

Oct 07, 2022
SELL
$28.79 - $35.41 $2,130 - $2,620
-74 Reduced 0.38%
19,398 $657,000
Q2 2022

Jul 20, 2022
BUY
$25.33 - $34.25 $11,246 - $15,207
444 Added 2.33%
19,472 $563,000
Q1 2022

Apr 26, 2022
SELL
$28.51 - $32.9 $787,075 - $908,270
-27,607 Reduced 59.2%
19,028 $615,000
Q4 2021

Jan 13, 2022
BUY
$26.37 - $34.22 $21,438 - $27,820
813 Added 1.77%
46,635 $1.36 Million
Q3 2021

Oct 18, 2021
BUY
$23.54 - $31.39 $228,738 - $305,016
9,717 Added 26.91%
45,822 $1.22 Million
Q2 2021

Jul 30, 2021
BUY
$26.72 - $33.19 $91,729 - $113,941
3,433 Added 10.51%
36,105 $1.11 Million
Q1 2021

Apr 20, 2021
BUY
$24.15 - $31.45 $105,342 - $137,184
4,362 Added 15.41%
32,672 $855,000
Q4 2020

Jan 19, 2021
BUY
$17.7 - $25.81 $48,852 - $71,235
2,760 Added 10.8%
28,310 $712,000
Q3 2020

Oct 30, 2020
BUY
$20.2 - $25.05 $89,162 - $110,570
4,414 Added 20.88%
25,550 $532,000
Q2 2020

Jul 15, 2020
BUY
$17.09 - $24.89 $361,214 - $526,075
21,136 New
21,136 $502,000

Others Institutions Holding SUPN

# of Institutions
327
Shares Held
59.6M
Call Options Held
19.1K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.38B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email